| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8474555 | Journal of Molecular and Cellular Cardiology | 2014 | 16 Pages |
Abstract
Inhibiting myocardial cell death and fibrosis after acute myocardial infarction (AMI via permanent LAD ligation) is attenuated with treatment post-MI with a cell permeant peptide targeting MAPK kinase 2 (MK2)-MMI-0100. Daily MMI-0100 treatment results in improved function and decreased LV dilation in the 2Â weeks post-AMI investigated.185
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Lei Xu, Cecelia C. Yates, Pamela Lockyer, Liang Xie, Ariana Bevilacqua, Jun He, Cynthia Lander, Cam Patterson, Monte Willis,